Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment

Overexpression of human epidermal growth factor receptor 2 (HER2) is found in about 20% of breast cancer patients. With treatment using trastuzumab, an anti-HER2 monoclonal antibody, systemic control is improved. Nonetheless, the incidence of brain metastasis does not be improved, rather seems to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Koo, Taeryool, Kim, In Ah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831963/
https://www.ncbi.nlm.nih.gov/pubmed/27104161
http://dx.doi.org/10.3857/roj.2016.34.1.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831963/
https://www.ncbi.nlm.nih.gov/pubmed/27104161
http://dx.doi.org/10.3857/roj.2016.34.1.1

Ejemplares similares